-
Prognostic Significance of Measurable Residual Disease Detection by Flow Cytometry in Autologous Stem Cell Apheresis Products in AML
Tettero, J. M., Buisman, Y., Ngai, L. L., Bachas, C., Gjertsen, B. T., Kelder, A., van de Loosdrecht, A. A., Manz, M. G., Pabst, T., Scholten, W., Ossenkoppele, G. J., Cloos, J. & de Leeuw, D. C., 21 Dec 2023, In: HemaSphere. 7, 12, p. E981Research output: Contribution to journal › Article › Academic › peer-review
-
Measurable residual disease-guided therapy in intermediate-risk acute myeloid leukemia patients is a valuable strategy in reducing allogeneic transplantation without negatively affecting survival
Tettero, J. M., Ngai, L. L., Bachas, C., Breems, D. A., Fischer, T., Gjertsen, B. T., Gradowska, P., Griskevicius, L., Janssen, J. J. W. M., Juliusson, G., Maertens, J., Manz, M. G., Pabst, T., Passweg, J., Porkka, K., Valk, P. J. M., Löwenberg, B., Ossenkoppele, G. J. & Cloos, J., 1 Oct 2023, In: Haematologica. 108, 10, p. 2794-2798 5 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Prospective validation of the prognostic relevance of CD34+CD38– AML stem cell frequency in the HOVON-SAKK132 trial
Ngai, L. L., Hanekamp, D., Janssen, F., Carbaat-Ham, J., Hofland, M. A. M. A., Fayed, M. M. H. E., Kelder, A., Oudshoorn-van Marsbergen, L., Scholten, W. J., Snel, A. N., Bachas, C., Tettero, J. M., Breems, D. A., Fischer, T., Gjertsen, B. T., Griškevičius, L., Juliusson, G., van de Loosdrecht, A. A., Maertens, J. A., Manz, M. G., & 10 others , 25 May 2023, In: Blood. 141, 21, p. 2657-2661 5 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications